Masimo Corporation (LON:0JZ2)

Market Cap	7.20B
Revenue (ttm)	1.52B
Net Income (ttm)	58.66M
Shares Out	n/a
EPS (ttm)	1.08
PE Ratio	122.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	305
Average Volume	325
Open	178.47
Previous Close	176.02
Day's Range	171.10 - 178.47
52-Week Range	75.35 - 197.07
Beta	1.02
RSI	43.75
Earnings Date	Feb 25, 2025

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1989
• Employees: 3,800
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JZ2

Financial Performance

In 2023, Masimo's revenue was $2.05 billion, an increase of 0.60% compared to the previous year's $2.04 billion. Earnings were $81.50 million, a decrease of -43.21%.

Financial numbers in USD